The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
ahr null alleles: distinctive or different?
Abstract
Two independent laboratories have generated Ahr "null" or "knockout" mice that share some common characteristics but also have distinct phenotypes. In this Commentary, we will discuss our view of the candidate variables that might account for these differences. More importantly, we hope that this discussion can identify important parameters to be assessed by investigators in the process of characterizing their own modified loci. The variables that we have considered include the possibility that different targeting strategies can result in altered products with unsuspected function or that the targeting event itself can alter the function of neighboring genes. Further, genetic background can have an important influence on phenotype, and differences in genome can be introduced during derivation by the type of embryonic stem cells used and by the random segregation of parental genes in the F2 generation of line propagation. In addition, phenotype may be acutely sensitive to environmental variables, such as pathogen and chemical exposure and stress introduced by crowding and disease. Finally, we discuss approaches to resolving differences between null mice and propose a partial solution, the institution of a repository for detailed information on targeted alleles that may not typically be allowed in today's "fast paced" scientific publications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite inconsistent reports in initial characterization of these three models, subsequent examination of these alleles has indicated that all phenotypes are in fact quite similar and the variation is due to genetic background, environmental variables, or distinct laboratory emphasis (Lahvis & Bradfield, 1998).”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Lahvis & Bradfield, 1998
Citations
Cites
Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant Phenotype
Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C., et al. (1995) · Science · doi:10.1126/science.7618084 · Cited by 1,179
Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1995) · Science · doi:10.1126/science.7732381 · Cited by 1,075
Strain-Dependent Epithelial Defects in Mice Lacking the EGF Receptor
Sibilia, M., & Wagner, E. F. (1995) · Science · doi:10.1126/science.7618085 · Cited by 1,002
Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., & Bradfield, C. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6731 · Cited by 902
Self-citationFernández‐Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0210 · Cited by 835
Mouse genetics: concepts and applications
(1995) · Choice Reviews Online · doi:10.5860/choice.33-2135 · Cited by 757
Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
Simpson, E. M., Linder, C. C., Sargent, E. E., Davisson, M. T., Mobraaten, L. E., & Sharp, J. J. (1997) · Nature Genetics · doi:10.1038/ng0597-19 · Cited by 684
Know Your Neighbors: Three Phenotypes in Null Mutants of the Myogenic bHLH Gene MRF4
Olson, E. N., Arnold, H.-H., Rigby, P. W. J., & Wold, B. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81073-9 · Cited by 577
Poland, A., & Glover, E. A. (1977) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12455-3 · Cited by 353
Tumour promotion by TCDD in skin of HRS/J hairless mice
Poland, A., Palen, D., & Glover, E. A. (1982) · Nature · doi:10.1038/300271a0 · Cited by 294
Research works printed but not linked: 1
- Poland, 1977, Chlorinated biphenyl induction of aryl hydrocarbon hydroxylase activity, Mol Pharmacol, 13, 924
Cited by
Sorted by citations
The PAS Superfamily: Sensors of Environmental and Developmental Signals
Gu, Y.-Z., Hogenesch, J. B., & Bradfield, C. A. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.519 · Cited by 1,044
Self-citationExogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation
Li, Y., Innocentin, S., Withers, D. R., Roberts, N. A., Gallagher, A., Grigorieva, E. F., Wilhelm, C., & Veldhoen, M. (2011) · Cell · doi:10.1016/j.cell.2011.09.025 · Cited by 837
The Search for Endogenous Activators of the Aryl Hydrocarbon Receptor
Nguyen, L. P., & Bradfield, C. A. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7001965 · Cited by 718
Self-citationAhR signaling pathways and regulatory functions
Larigot, L., Juricek, L., Dairou, J., & Coumoul, X. (2018) · Biochimie Open · doi:10.1016/j.biopen.2018.05.001 · Cited by 563
Ligand binding and activation of the Ah receptor
Denison, M. S., Pandini, A., Nagy, S. R., Baldwin, E. P., & Bonati, L. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00063-7 · Cited by 485
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system
Stevens, E. A., Mezrich, J. D., & Bradfield, C. A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03054.x · Cited by 425
Self-citationLahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., & Bradfield, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190256997 · Cited by 377
Self-citationKolluri, S. K., Weiss, C., Koff, A., & Göttlicher, M. (1999) · Genes & Development · doi:10.1101/gad.13.13.1742 · Cited by 364
Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor
Hankinson, O. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.031 · Cited by 337
Kim, D. W., Gazourian, L., Quadri, S. A., Raphaëlle, Sherr, D. H., & Sonenshein, G. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203945 · Cited by 280
Nebert, D. W. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.06.001 · Cited by 286
Estrogen receptor and aryl hydrocarbon receptor signaling pathways
Matthews, J. B., & Gustafsson, J.-Α. (2006) · Nuclear Receptor Signaling · doi:10.1621/nrs.04016 · Cited by 277
Okey, A. B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm096 · Cited by 264
Bunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., & Bradfield, C. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209594200 · Cited by 215
Self-citationBarouki, R., & Morel, Y. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00543-8 · Cited by 190
Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders
Busbee, P. B., Rouse, M. D., Nagarkatti, M., & Nagarkatti, P. S. (2013) · Nutrition Reviews · doi:10.1111/nure.12024 · Cited by 197
The Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems
McMillan, B. J., & Bradfield, C. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037259 · Cited by 183
Self-citationRole of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target
Kolluri, S. K., Jin, U.-H., & Safe, S. H. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1981-2 · Cited by 181
Thatcher, T. H., Maggirwar, S. B., Baglole, C. J., Lakatos, H. F., Gasiewicz, T. A., Phipps, R. P., & Sime, P. J. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060391 · Cited by 171
Vorderstrasse, B. A., Steppan, L. B., Silverstone, A. E., & Kerkvliet, N. I. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.9122 · Cited by 162
Redox regulation of signal transduction in mammalian cells
Herrlich, P. A., & Böhmer, F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00298-1 · Cited by 158
The aryl hydrocarbon receptor and the gut–brain axis
Barroso, A., Mahler, J. V., Fonseca-Castro, P. H., & Quintana, F. J. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00585-5 · Cited by 152
Jux, B., Kadow, S., & Esser, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0713344 · Cited by 147
The Ah Receptor: Adaptive Metabolism, Ligand Diversity, and the Xenokine Model
Avilla, M. N., Malecki, K. M. C., Hahn, M. E., Wilson, R. H., & Bradfield, C. A. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00476 · Cited by 148
Self-citationActivation of the Ah Receptor Signaling Pathway by Prostaglandins
Seidel, S. D., Winters, G. M., Rogers, W. J., Ziccardi, M. H., Li, V., Keser, B., & Denison, M. S. (2001) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.16 · Cited by 144
Bunger, M. K., Glover, E., Moran, S. M., Walisser, J. A., Lahvis, G. P., Hsu, E. L., & Bradfield, C. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn149 · Cited by 139
Self-citationAryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs)
Safe, S. H., Jin, U.-H., Park, H., Chapkin, R. S., & Jayaraman, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186654 · Cited by 143
Latchney, S. E., Hein, A. M., O’Banion, M. K., DiCicco-Bloom, E. M., & Opanashuk, L. A. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12130 · Cited by 139
Bulmer, A. C., Verkade, H. J., & Wagner, K. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.11.001 · Cited by 133
Roberts, B. J., & Whitelaw, M. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36351 · Cited by 132
Mouse Phenome Research: Implications of Genetic Background
Yoshiki, A., & Moriwaki, K. (2006) · ILAR Journal · doi:10.1093/ilar.47.2.94 · Cited by 129
OKEY, A., FRANC, M., MOFFAT, I., TIJET, N., BOUTROS, P., KORKALAINEN, M., TUOMISTO, J., & POHJANVIRTA, R. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.12.028 · Cited by 122
Timing is everything: Consequences of transient and sustained AhR activity
Mitchell, K. A., & Elferink, C. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.028 · Cited by 120
Chopra, M., & Schrenk, D. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2010.524635 · Cited by 114
Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance
Lindén, J., Lensu, S., Tuomisto, J., & Pohjanvirta, R. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.07.002 · Cited by 108
Diliberto, J. J., Burgin, D. E., & Birnbaum, L. S. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8720 · Cited by 102
Evidence for an Aryl Hydrocarbon Receptor-Mediated Cytochrome P450 Autoregulatory Pathway
Chiaro, C. R., Patel, R. D., Marcus, C. B., & Perdew, G. H. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038968 · Cited by 99
Yamauchi, M., Kim, E., Iwata, H., Shima, Y., & Tanabe, S. (2006) · Aquatic Toxicology · doi:10.1016/j.aquatox.2006.08.006 · Cited by 93
The aryl hydrocarbon receptor: structure, signaling, physiology and pathology
Coumoul, X., Barouki, R., Esser, C., Haarmann‐Stemmann, T., Lawrence, B. P., Lehmann, J., Moura‐Alves, P., Murray, I. A., Opitz, C. A., Perdew, G. H., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02500-8 · Cited by 111
Hu, P., Herrmann, R., Bednar, A., Saloupis, P., Dwyer, M. A., Yang, P., Qi, X., Thomas, R. S., Jaffe, G. J., Boulton, M. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307574110 · Cited by 93
Hahn, M. E. (2001) · Marine Biotechnology · doi:10.1007/s10126-001-0045-y · Cited by 90
Dertinger, S. D. (2001) · Carcinogenesis · doi:10.1093/carcin/22.1.171 · Cited by 76
Kim, S.-Y., Yang, H.-J., Chang, Y.-S., Kim, J.-W., Brooks, M., Chew, E. Y., Wong, W. T., Fariss, R. N., Rachel, R. A., Cogliati, T., et al. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-15091 · Cited by 72
The aryl hydrocarbon receptor in liver inflammation
Carambia, A., & Schuran, F. A. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00867-8 · Cited by 74
Esser, C. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.002 · Cited by 74
Receptor- and Reactive Intermediate-Mediated Mechanisms of Teratogenesis
Wells, P. G., Lee, C. J. J., McCallum, G. P., Perstin, J., & Harper, P. A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_6 · Cited by 69
Furness, S. G. B., & Whelan, F. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.09.004 · Cited by 63
New insights into the aryl hydrocarbon receptor as a modulator of host responses to infection
Lawrence, B. P., & Vorderstrasse, B. A. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0395-3 · Cited by 68
Kiss, E. A., & Diefenbach, A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00124 · Cited by 65
Kung, M. H., Yukata, K., O’Keefe, R. J., & Zuscik, M. J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22819 · Cited by 57
The cyclic AMP phenotype of fragile X and autism
Kelley, D. J., Bhattacharyya, A., Lahvis, G. P., YIN, J., Malter, J. S., & Davidson, R. J. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.06.005 · Cited by 60
Self-citationFranc, M. A., Pohjanvirta, R., Tuomisto, J., & Okey, A. B. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00820-6 · Cited by 56
The Role of the Kynurenine/AhR Pathway in Diseases Related to Metabolism and Cancer
Shadboorestan, A., Koual, M., Dairou, J., & Coumoul, X. (2023) · International Journal of Tryptophan Research · doi:10.1177/11786469231185102 · Cited by 58
Effects of Histone Deacetylase Inhibitors on the Ah Receptor Gene Promoter
Garrison, P. M., Rogers, J. M., Brackney, W. R., & Denison, M. S. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1620 · Cited by 53
Burchiel, S. W. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.2.193 · Cited by 53
How Ah Receptor Ligand Specificity Became Important in Understanding Its Physiological Function
Murray, I. A., & Perdew, G. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249614 · Cited by 57
Choudhary, M., Kazmin, D. A., Hu, P., Thomas, R. S., McDonnell, D. P., & Malek, G. (2014) · The Journal of Pathology · doi:10.1002/path.4433 · Cited by 48
Kolluri, S. K., Balduf, C., Hofmann‐Apitius, M., & Göttlicher, M. (2001) · PubMed · Cited by 46
Sonneveld, E., Jonas, A., Meijer, O. C., Brouwer, A., & van der Burg, B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm176 · Cited by 45
Pocar, P., Augustin, R., & Fischer, B. (2004) · Endocrinology · doi:10.1210/en.2003-1254 · Cited by 45
Linking long-term toxicity of xeno-chemicals with short-term biological adaptation
Barouki, R. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.026 · Cited by 42
Functional interaction of nuclear receptor coactivator 4 with aryl hydrocarbon receptor
Kollara, A., & Brown, T. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.148 · Cited by 42
Endogenous ligands of the aryl hydrocarbon receptor regulate lung dendritic cell function
Thatcher, T. H., Williams, M. A., Pollock, S. J., McCarthy, C. E., Lacy, S. H., Phipps, R. P., & Sime, P. J. (2015) · Immunology · doi:10.1111/imm.12540 · Cited by 48
Genetically altered mice: phenotypes, no phenotypes, and Faux phenotypes
Barthold, S. W. (2004) · Genetica · doi:10.1007/s10709-004-1439-3 · Cited by 41
Alsaad, A. M. S., Al-Arifi, M. N., Maayah, Z. H., Attafi, I. M., Alanazi, F. E., Belali, O. M., Alhoshani, A., Asiri, Y. A., & Korashy, H. M. (2018) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2018.1528650 · Cited by 37
Franc, M.-A., Pohjanvirta, R., Tuomisto, J., & Okey, A. B. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9222 · Cited by 37
Microbial Considerations in Genetically Engineered Mouse Research
Franklin, C. L. (2006) · ILAR Journal · doi:10.1093/ilar.47.2.141 · Cited by 38
Zhou, Y., Jiang, R., An, L., Wang, H., Cheng, S., Shi, Q., & Weng, Y. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.02.152 · Cited by 37
Kiss, E. A., & Vonarbourg, C. (2012) · Gut Microbes · doi:10.4161/gmic.21865 · Cited by 35
Pohjanvirta, R. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.01.005 · Cited by 32
A Maternal Ahr Null Genotype Sensitizes Embryos to Chemical Teratogenesis
Thomae, T. L., Glover, E. A., & Bradfield, C. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403690200 · Cited by 30
Self-citationThe Human CYP1A1 Gene Is Regulated in a Developmental and Tissue-specific Fashion in Transgenic Mice
Galijatovic, A., Beaton, D., Nguyen, N. T., Chen, S., Bonzo, J. A., Johnson, R. S., Maeda, S., Karin, M., Guengerich, F. P., & Tukey, R. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400973200 · Cited by 27
Effect of 3′-methoxy-4′-nitroflavone on benzo[a]pyrene toxicity
Dertinger, S. D., Lantum, H. B. M., Silverstone, A. E., & Gasiewicz, T. A. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00314-2 · Cited by 27
Unnisa, Z., Singh, K. P., Henry, E. C., Donegan, C. L., Bennett, J. A., & Gasiewicz, T. A. (2016) · Stem Cells International · doi:10.1155/2016/4536187 · Cited by 26
Lindén, J., Lensu, S., & Pohjanvirta, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813938 · Cited by 25
Spontaneous Irs1 passenger mutation linked to a gene-targeted SerpinB2 allele
Westrick, R. J., Mohlke, K. L., Korepta, L. M., Yang, A. Y., Zhu, G., Manning, S. L., Winn, M. E., Dougherty, K. M., & Ginsburg, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012050107 · Cited by 25
Brokken, L. J. S., & Giwercman, Y. L. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122193 · Cited by 25
Rataj, F., Möller, F. J., Jähne, M., Zierau, O., Diel, P. R., Vollmer, G., & Kretzschmar, G. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0870-y · Cited by 22
Uric acid stones in the urinary bladder of aryl hydrocarbon receptor (AhR) knockout mice
Butler, R., Inzunza, J., Suzuki, H., Fujii‐Kuriyama, Y., Warner, M. N., & Gustafsson, J.-Α. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120581109 · Cited by 22
AH receptor antagonist inhibits constitutive CYP1A1 and CYP1B1 expression in rat BP8 cells
Roblin, S., Okey, A. B., & Harper, P. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.016 · Cited by 22
Nazarenko, D. A. (2001) · Toxicological Sciences · doi:10.1093/toxsci/61.2.256 · Cited by 22
Daujat‐Chavanieu, M., & Kot, M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107616 · Cited by 22
Iqbal, K., Pierce, S. H., Kozai, K., Dhakal, P., Scott, R. L., Roby, K. F., Vyhlidal, C. A., & Soares, M. J. (2021) · Environmental Health Perspectives · doi:10.1289/ehp9256 · Cited by 20
Lew, B. J., Manickam, R., & Lawrence, B. P. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.110.087544 · Cited by 22
Receptors mediating toxicity and their involvement in endocrine disruption
Rüegg, J., Damdimopoulou, P., Mäkelä, S., Pongratz, I., & Gustafsson, J.-Α. (2009) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-7643-8336-7_11 · Cited by 21
Esteban, J., Sánchez-Pérez, I., Hamscher, G., Miettinen, H. M., Korkalainen, M., Viluksela, M., Pohjanvirta, R., & Håkansson, H. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.02.004 · Cited by 20
Bemis, J. C., Nazarenko, D. A., & Gasiewicz, T. A. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi260 · Cited by 20
Apoptosis in Ovarian Development, Function, and Failure
Tilly, J. L., Pru, J. K., & Rueda, B. R. (2004) · Elsevier eBooks · doi:10.1016/b978-012444562-8/50020-3 · Cited by 20
Lawrence, B. P., & Sherr, D. H. (2012) · Nature Immunology · doi:10.1038/ni.2213 · Cited by 18
Carter, H. M., Costa, R. M., Adams, T. S., Gilchrist, T. M., Emch, C. E., Bame, M., Oldham, J. M., Huang, S. K., Linderholm, A., Noth, I., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.177072 · Cited by 18
Role of Hepatic Aryl Hydrocarbon Receptor in Non-Alcoholic Fatty Liver Disease
Patil, N. Y., Friedman, J. E., & Joshi, A. (2023) · Receptors · doi:10.3390/receptors2010001 · Cited by 17
Dietary and metabolic modulators of hepatic immunity
Carambia, A., & Herkel, J. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0659-4 · Cited by 17
Rodent Genetic Models of Ah Receptor Signaling
Wilson, R. H., & Bradfield, C. A. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1955916 · Cited by 16
“…reports in initial characterization of these three models, subsequent examination of these alleles has indicated that all phenotypes are in fact quite similar and the variation is due to genetic background, environmental variables, or distinct laboratory emphasis (Lahvis and Bradfield 1998).”
ResultSelf-citationBarouki, R., & Coumoul, X. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.1.10313 · Cited by 20
Cui, Y., Yeager, R. L., Zhong, X., & Klaassen, C. D. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.05.017 · Cited by 16
Jorge-Nebert, L. F., Zhang, G., Wilson, K. M. O., Jiang, Z., Butler, R., Gluckman, J. L., Pinney, S. M., & Nebert, D. W. (2016) · Human Genomics · doi:10.1186/s40246-016-0094-y · Cited by 14
Loss of the aryl hydrocarbon receptor increases tumorigenesis in p53-deficient mice
Phillips, J. L., Löhr, C. V., Nguyen, B. D., Buermeyer, A. B., & Kolluri, S. K. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116191 · Cited by 14
Xenobiotic-metabolizing cytochrome P450 enzymes in human lung
Hukkanen, J. (2000) · Cited by 14
History of Research on the AHR
Gasiewicz, T. A., & Henry, E. C. (2011) · Wiley eBooks · doi:10.1002/9781118140574.ch1 · Cited by 14
A case of PDH‐E1α mosaicism in a male patient with severe metabolic lactic acidosis
Seyda, A., Chun, K., Packman, S., & Robinson, B. H. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1012463726810 · Cited by 13
Metadata
- Authors
- Lahvis, G. P., & Bradfield, C. A.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Bradfield, Christopher A
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 1998-10
- Volume
- 56
- Issue
- 7
- Pages
- 781-787
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2131562982
- Cited by
- 152
- References
- 25
- Citations by year
- 2026: 2 · 2025: 3 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 8 · 2015: 2 · 2014: 5 · 2013: 8 · 2012: 9
- FWCI
- 7.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p30ca007175-36)
- National Cancer Institute (P30 CA 07175)
- National Institute of Environmental Health Sciences (ES06883, R01ES006883)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- aryl hydrocarbon receptor, knockout mice, genetic background effects, embryonic stem cell derivation, phenotypic variability
- MeSH terms
- Alleles, Animals, Crosses, Genetic, Models, Biological, Pedigree, Phenotype, Receptors, Aryl Hydrocarbon, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review